REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $234,312 | -23.4% | 19,916 | +37.1% | 0.00% | – |
Q1 2024 | $306,084 | -39.3% | 14,527 | -48.4% | 0.00% | – |
Q4 2023 | $503,936 | -1.3% | 28,145 | -8.0% | 0.00% | -100.0% |
Q3 2023 | $510,719 | -32.5% | 30,582 | -18.4% | 0.00% | 0.0% |
Q2 2023 | $756,539 | +30.8% | 37,471 | +20.6% | 0.00% | 0.0% |
Q1 2023 | $578,399 | +57.2% | 31,080 | +88.4% | 0.00% | – |
Q4 2022 | $367,840 | +12.1% | 16,495 | +35.0% | 0.00% | -100.0% |
Q3 2022 | $328,000 | +56.2% | 12,219 | +45.4% | 0.00% | – |
Q2 2022 | $210,000 | -34.6% | 8,406 | -11.8% | 0.00% | – |
Q1 2022 | $321,000 | +4.2% | 9,533 | +22.4% | 0.00% | – |
Q2 2021 | $308,000 | -35.8% | 7,788 | -44.6% | 0.00% | -100.0% |
Q1 2021 | $480,000 | -70.8% | 14,063 | -68.5% | 0.00% | -66.7% |
Q2 2020 | $1,642,000 | +656.7% | 44,578 | +743.8% | 0.00% | – |
Q4 2019 | $217,000 | -13.2% | 5,283 | -24.8% | 0.00% | – |
Q3 2019 | $250,000 | -20.9% | 7,021 | +14.4% | 0.00% | -100.0% |
Q2 2019 | $316,000 | +3.9% | 6,138 | +15.6% | 0.00% | 0.0% |
Q1 2019 | $304,000 | – | 5,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
Atom Investors LP | 36,487 | $901,000 | 0.39% |